Cellular Biomedicine (CBMG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,029 | 13,582 | 21,597 | 32,444 | 46,036 |
| Receivables | 330 | 299 | 254 | 751 | 591 |
| TOTAL | $27,871 | $14,975 | $23,558 | $34,030 | $48,216 |
| Non-Current Assets | |||||
| PPE Net | 24,686 | 22,444 | 21,338 | 21,434 | 19,856 |
| Investments And Advances | 0 | 0 | 0 | 240 | 240 |
| Intangibles | 14,126 | 14,426 | 14,714 | 15,056 | 15,200 |
| Other Non-Current Assets | 26,403 | 25,723 | 26,278 | 26,565 | 21,939 |
| TOTAL | $65,215 | $62,593 | $62,330 | $63,295 | $57,236 |
| Total Assets | $93,086 | $77,568 | $85,889 | $97,324 | $105,452 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 47,870 | 19,475 | 14,000 | 14,334 | 14,138 |
| Accounts payable and accrued liabilities | 2,748 | 1,517 | 1,620 | 2,040 | 5,686 |
| Accrued Expenses | 1,726 | 1,707 | 2,372 | 1,905 | 1,477 |
| Other current liabilities | 6,923 | 5,723 | 5,509 | 5,368 | 4,527 |
| TOTAL | $59,297 | $28,452 | $23,533 | $23,673 | $25,857 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 16,466 | 16,584 | 17,205 | 17,934 | 12,545 |
| TOTAL | $16,466 | $16,584 | $17,205 | $17,934 | $12,545 |
| Total Liabilities | $75,763 | $45,036 | $40,737 | $41,607 | $38,402 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,459 | 19,433 | 19,391 | 19,355 | 19,281 |
| Common Shares | 21 | 21 | 20 | 20 | 20 |
| Retained earnings | -242,084 | -225,046 | -211,514 | -199,967 | -187,280 |
| Other shareholders' equity | -952 | -1,847 | -1,891 | -1,454 | -1,765 |
| TOTAL | $17,324 | $32,533 | $45,151 | $55,718 | $67,050 |
| Total Liabilities And Equity | $93,086 | $77,568 | $85,888 | $97,324 | $105,452 |